Thursday, July 2, 2026 See who Washington just made rich Go Pro · $40/mo →
Money Racket
Who Cashes In When Washington Moves
DEFENSEThe F-35 Sustainment Lock-In: Why the Pentagon's Most Expensive Program Keeps Paying One Company ForevertodayHEALTHCARE340B Under Fire: The Hospital Drug Discount Fight That Hits CVS and HCA Where It Hurts4 weeks agoTRADE & TARIFFSThe Tariff Refund Portal Is Open and Companies Are Cashing In — Nike and FedEx Are the Names to WatchyesterdayHEALTHCAREGLP-1 Coverage Mandate: The Federal Obesity Drug Windfall for Lilly and Novo4 weeks agoMARKETSSupreme Court Gives Trump FTC Firing Power — Antitrust Enforcement Just Got More PoliticalyesterdayHEALTHCAREFDA Accelerated Approval Reform: The Vertex Model Every Biotech Wants4 weeks agoTRADE & TARIFFSTrump's Fertilizer Tariff Suspension Cuts Input Costs for Farmers — and Squeezes Domestic ProducersyesterdayHEALTHCAREThe Medicare Drug Negotiation Trade: Who Gets Hurt When Washington Sets the Price4 weeks agoDEFENSEThe Nuclear Triad Upgrade Cycle: Three Legs, Three Winners, Decades of Locked-In SpendingyesterdayCRYPTOThe Anti-CBDC Play: No Digital Dollar Means Private Rails Win4 weeks agoDEFENSEWhen the Pentagon Classifies a Budget Line: The Black Budget Trade2 days agoCRYPTOThe Toll Booth at the Top of the Bitcoin ETF Stack4 weeks agoDEFENSENATO's 2% Mandate Is a Revenue Stream Disguised as an Alliance Obligation3 days agoCRYPTOThe IRS Closes the Crypto Wash-Sale Loophole — and Robinhood Collects the Toll4 weeks agoDEFENSEThe Drone Proliferation Trade: Washington's Shift to Attritable Unmanned Systems Creates a Recurring Revenue Stream3 days agoCRYPTOThe Debanking Era Is Over. HOOD and Block Are Next in Line at the Window.4 weeks agoDEFENSEThe Hypersonic Arms Race Has a Bottleneck — and Three Contractors Own It4 days agoCRYPTOMining the Grid: How EPA and Energy Policy Set the Spread for Proof-of-Work Miners3 weeks agoDEFENSEThe Pentagon's AI Mandate: Why Defense Data Platforms Are Now a Weapons Program5 days agoCRYPTOThe Stablecoin Bill: Who Controls the On-Ramp When Congress Licenses It3 weeks agoDEFENSEIron Dome and the FMS Pipeline: How Middle East Tensions Fund Missile Defense Primes5 days agoCRYPTOBitcoin as Reserve Asset: The Federal Legitimacy Trade3 weeks agoENERGYThe SPR Refill Trade: Who Gets Paid When Washington Buys Oil6 days agoCRYPTOThe SEC Retreat: How a Friendlier Regulator Unlocks Coinbase's Business Model3 weeks agoENERGYLNG Export Licenses: How a FERC Approval Mints a Monopolylast weekTECHThe Federal Data Center Mandate: How Washington's AI Spending Flows to Hardware3 weeks agoENERGYThe BLM Calendar That Moves COP and OXYlast weekTECHThe Domestic Equipment Play: How Foreign Chip Tool Restrictions Hand Applied Materials a Structural Edge3 weeks agoENERGYThe Permian Methane Rule: Why Stricter EPA Standards Are a HAL and SLB Giftlast weekTECHThe AI Diffusion Rule Is Picking Winners Inside the Chip Stack — and It Is Not Who You Think3 weeks agoENERGYThe Permit Logjam Is Breaking: Williams and Kinder Morgan Hold the Keyslast weekTECHThe HBM Monopoly: How Federal Memory Standards Lock In Micron3 weeks agoENERGYThe Tax Code Oil Patch: Who Gets Crushed If Washington Kills the IDC Deductionlast weekTECHThe Tariff Arbitrage: How Chip Import Duties Reshape the Foundry Map3 weeks agoENERGYThe Pipe Tax: How Section 232 Steel Tariffs Rewire U.S. Drilling Economicslast weekTECHThe Chip Stack Below the Pentagon's AI Buildup3 weeks agoENERGYSanctions Relief and the LNG Arbitrage: When State Department Decisions Move the Henry Hublast weekTECHThe CHIPS Act Subsidy Ladder: Who Actually Receives the $39 Billion3 weeks agoENERGYThe Nuclear Production Tax Credit Trade: Who Gets Paid to Keep Old Reactors Alivelast weekENERGYThe Grid Hardening Bill Trade: How Federal Transmission Investment Lifts the Equipment Makers2 weeks agoENERGYThe Uranium Supply Squeeze: How the Russian Import Ban Flows to Cameco and Centruslast weekTECHThe Export Control Squeeze: BIS Chip Rules Are Splitting the AI Hardware Market in Two2 weeks agoENERGYThe SMR Funding Funnel: How DOE's Loan Billions Flow to Small Modular Reactorslast weekENERGYThe Only U.S. HALEU Cascade: How Centrus Became the Gatekeeper to the Advanced Reactor Boom2 weeks agoENERGYWashington Plugs AI Into Reactors: The Behind-the-Meter Nuclear Offtake Trade2 weeks agoENERGYThe Grid Reliability Mandate: FERC's Capacity Market Rules Are Writing Checks to Nuclear2 weeks agoENERGYThe Nuclear Restart Order: Only One Operator Has Actually Flipped the Switch2 weeks ago
1 free article left this week. A free account gets you 4 a week.Go Pro →
Healthcare

Medicaid Work Requirements Return: The Managed Care Revenue Equation

Federal waivers reinstating Medicaid work requirements will shrink enrollment rolls — and the per-member-per-month revenue that UNH and CVS count on.

Image: Money Racket
By at Money Racket · May 31, 2026

Washington is bringing back Medicaid work requirements, and the mechanism is straightforward: states that receive federal waiver approval can require able-bodied adults to document employment, job training, or community service hours to maintain coverage. When enrollees can't or don't comply — whether from paperwork burden, part-time status, or gaps in verification — they disenroll. Fewer members means fewer per-member-per-month (PMPM) capitation payments flowing to managed care organizations (MCOs). The policy catalyst doesn't touch Medicare Advantage or commercial insurance; it carves into Medicaid managed care, which is a meaningful revenue line for several large insurers.

Who cashes in:

Fewer members means fewer per-member-per-month capitation payments flowing to managed care organizations — and the policy doesn't touch commercial insurance at all.

HCA (HCA) operates the largest for-profit hospital network in the country, and hospitals collect on a different margin calculus than MCOs. When Medicaid enrollment contracts, the payer mix among remaining patients may shift toward commercially insured and Medicare patients — higher-reimbursement categories. HCA's facilities are concentrated in states like Texas and Florida that have historically supported work requirements, where the enrollment churn could actually improve realized reimbursement per admission.

Vertex (VRTX) earns virtually nothing from Medicaid managed care. Its cystic fibrosis franchise — Trikafta and successors — commands payer-agnostic reimbursement and targets a rare-disease population with durable commercial and Medicare coverage. Medicaid enrollment swings are essentially irrelevant to VRTX's revenue base, making it a relative safe harbor within the healthcare sector during this policy cycle.

Eli Lilly (LLY) sits similarly insulated on the drug side. Its GLP-1 obesity and diabetes portfolio — Mounjaro and Zepbound — skews heavily toward commercially insured patients. Medicaid coverage of GLP-1s for obesity has been limited anyway, so a contraction in Medicaid rolls does little damage to Lilly's realized demand curve.

Who is exposed:

UnitedHealth (UNH) runs Optum Health and UnitedHealthcare's Medicaid managed care business across dozens of states. Medicaid is not UNH's largest segment, but it is material — the company manages millions of Medicaid beneficiaries under state contracts priced as PMPM capitation. Enrollment attrition from work requirements compresses the top line without a proportional reduction in fixed administrative and care-management infrastructure.

CVS Health (CVS) carries significant Medicaid exposure through its Aetna subsidiary, which operates Medicaid MCO contracts in multiple expansion states. Aetna's commercial book is unaffected, but Medicaid represents a growth lever CVS has leaned on post-Aetna acquisition. Disenrollment pressure arrives at a moment when CVS is already navigating margin compression in its pharmacy benefits business.

What to watch: Track individual state waiver approval timelines on the Federal Register and monitor MCO enrollment figures in quarterly earnings supplements. The spread between Medicaid PMPM rates and administrative cost structures will tell you how much margin UNH and CVS absorb before they renegotiate state contracts upward — or exit markets.

Source: original report ↗

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $40/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Go Pro · $40/mo The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Go Pro · $40/mo →